Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3447 results

Sort By:

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Study ID: NCT07091617
Start Date: 2025-09-14
End Date: 2031-01-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

535

Intervention / Treatment

Telemedicine

Genetic Testing

Telemedicine

Internet-Based Intervention

Educational Intervention

Patient Navigation

Interview

Survey Administration

Sponsor

Alliance for Clinical Trials in Oncology

Source: clinicaltrials.gov

Share:
Add to list

Erector Spinae Plane Block in Congenital Heart Disease Patients

Study ID: NCT04158024
Start Date: 2025-11
End Date: 2026-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Erector spines Plane Block

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Benefits of no Fasting Compared to Fasting Prior to Elective Cardiac Catheterization: A Single-center Randomized-controlled Trial

Study ID: NCT07150780
Start Date: 2025-09-10
End Date: 2028-02-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

Pre-operative instructions to eat and drink at liberty

Sponsor

Munson Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Exposure to Persistent Organic Pollutants and Severity of Endometriosis in the ComPaRe-Endometriosis Cohort

Study ID: NCT06973603
Start Date: 2025-12
End Date: 2026-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

650

Intervention / Treatment

Blood samples

Sponsor

National Institute of Health and Medical Research, France

Source: clinicaltrials.gov

Share:
Add to list

Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF

Study ID: NCT04684212
Start Date: 2025-12-01
End Date: 2034-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2931

Intervention / Treatment

LAmbre PlusTM Left Atrial Appendage Closure System

Market approved oral anticoagulation (OAC), such as warfarin (Coumadin), dabigatran (Pradaxa), rivaroxaban (Xarelto), apixiban (Eliquis), edoxaban (Savaysa), or betrixaban (Bevyxxa)

Sponsor

Brian O'Neill MD

Source: clinicaltrials.gov

Share:
Add to list

Co-Creating Active Middle School Communities to Increase Student Physical Activity

Study ID: NCT06970067
Start Date: 2026-01-05
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment

Active Middle School Communities

Sponsor

Deanna Hoelscher

Source: clinicaltrials.gov

Share:
Add to list

Psychotrauma Prevention Algorithm : Randomized, Controlled Pilot Study

Study ID: NCT06366191
Start Date: 2025-10
End Date: 2026-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

prevention algorithm

Standard care

Sponsor

Reunion university hospital center

Source: clinicaltrials.gov

Share:
Add to list

Interaction Between Early Trauma and Odor-induced Dopamine Release

Study ID: NCT06284382
Start Date: 2025-10-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

High score at Childhood Trauma Questionnaire.

Low score at Childhood Trauma Questionnaire.

Sponsor

Le Vinatier Hospital

Source: clinicaltrials.gov

Share:
Add to list

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

Study ID: NCT06730100
Start Date: 2026-02-17
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

pH Low Insertion Peptide-exatecan Conjugate CBX-12

X-Ray Imaging

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

Study ID: NCT07091019
Start Date: 2025-11-15
End Date: 2033-05-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

TKIs

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list